The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1
Open accessAbstract
Glucocorticoids (GCs), which are used in the treatment of immune-mediated inflammatory diseases, inhibit the expression of many inflammatory mediators. They can also induce the expression of dual specificity phosphatase 1 (DUSP1; otherwise known as mitogen-activated protein kinase [MAPK] phosphatase 1), which dephosphorylates and inactivates MAPKs. We investigated the role of DUSP1 in the antiinflammatory action of the GC dexamethasone (Dex). Dex-mediated inhibition of c-Jun N-terminal kinase and p38 MAPK was abrogated in DUSP1-/- mouse macrophages. Dex-mediated suppression of several proinflammatory genes (including tumor necrosis factor, cyclooxygenase 2, and interleukin 1alpha and 1beta) was impaired in DUSP1-/- mouse macrophages, whereas other proinflammatory genes were inhibited by Dex in a DUSP1-independent manner. In vivo antiinflammatory effects of Dex on zymosan-induced inflammation were impaired in DUSP1-/- mice. Therefore, the expression of DUSP1 is required for the inhibition of proinflammatory signaling pathways by Dex in mouse macrophages. Furthermore, DUSP1 contributes to the antiinflammatory effects of Dex in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GR-mediated transactivation typically induces the expression of potent signaling inhibitors (e.g., IκBα, MPK-1, IL-10, Annexin A1, GILZ, and SOCS proteins), which strongly interfere with salient immune signaling pathways such as those triggered by the Toll-like receptors (TLR) (82–85).”
From The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain (2014) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068
Self-citationDual specificity phosphatases: a gene family for control of MAP kinase function
Camps, M., NICHOLS, A., & Arkinstall, S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.6 · Cited by 823
Possible new role for NF-κB in the resolution of inflammation
Lawrence, T., Gilroy, D. W., Colville‐Nash, P., & Willoughby, D. A. (2001) · Nature Medicine · doi:10.1038/nm1201-1291 · Cited by 753
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647
Chi, H., Barry, S. P., Flach, R. J. R., Wu, J. J., Jones, E. A., Bennett, A. M., & Flavell, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510965103 · Cited by 568
Molecular mechanisms of glucocorticoid action: what is important?
Newton, R. C. (2000) · Thorax · doi:10.1136/thorax.55.7.603 · Cited by 507
Swantek, J. L., Cobb, M. H., & Geppert, T. D. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6274 · Cited by 491
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor
Reichardt, H. M., Tuckermann, J. P., Göttlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P., & Schütz, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7168 · Cited by 429
MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock
Zhao, Q., Wang, X., Nelin, L. D., Yao, Y., Matta, R., Manson, M. E., Baliga, R. S., Meng, X., Smith, C. V., Bauer, J. A., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051794 · Cited by 370
Essential Role of MAPK Phosphatase-1 in the Negative Control of Innate Immune Responses
Salojin, K. V., Owusu, I. B., Millerchip, K. A., Potter, M. D., Platt, K. A., & Oravecz, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1899 · Cited by 333
Research works printed but not linked: 3
- 2005, Curr. Opin. Investig. Drugs., 6, 503
- 1996, Oncogene., 13, 925
- 2002, FASEB J., 16, 1832
Cited by
Sorted by citations
Mitogen-activated protein kinases in innate immunity
Arthur, J. S. C., & Ley, S. C. (2013) · Nature reviews. Immunology · doi:10.1038/nri3495 · Cited by 1,898
Coutinho, A. E., & Chapman, K. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.005 · Cited by 1,815
Resolution of in flammation: state of the art, definitions and terms
Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-7227rev · Cited by 1,045
Zhang, Y., Leung, D. Y. M., Richers, B. N., Liu, Y., Remigio, L. K., Riches, D. W. H., & Goleva, E. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102412 · Cited by 898
Glucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1564 · Cited by 708
MAPK phosphatases — regulating the immune response
Liu, Y., Shepherd, E. G., & Nelin, L. D. (2007) · Nature reviews. Immunology · doi:10.1038/nri2035 · Cited by 679
Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal Implant
Chang-Lin, J.-E., Attar, M., Acheampong, A., Robinson, M. R., Whitcup, S. M., Kuppermann, B. D., & Welty, D. F. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5285 · Cited by 601
Targeting dual-specificity phosphatases: Manipulating MAP kinase signalling and immune responses
Jeffrey, K. L., Camps, M., Rommel, C., & Mackay, C. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2289 · Cited by 533
Glucocorticosteroids: current and future directions
Barnes, P. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01199.x · Cited by 550
Dual-specificity MAP kinase phosphatases (MKPs) and cancer
Keyse, S. M. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9123-1 · Cited by 499
The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain
Bellavance, M.-A., & Rivest, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00136 · Cited by 419
Regulation of JNK and p38 MAPK in the immune system: Signal integration, propagation and termination
Huang, G., Shi, L. Z., & Chi, H. (2009) · Cytokine · doi:10.1016/j.cyto.2009.08.002 · Cited by 383
The role of the glucocorticoid receptor in inflammation and immunity
Baschant, U., & Tuckermann, J. P. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.058 · Cited by 354
Glucocorticoid‐induced leucine zipper (GILZ): a new important mediator of glucocorticoid action
Ayroldi, E., & Riccardi, C. (2009) · The FASEB Journal · doi:10.1096/fj.09-134684 · Cited by 348
O'Neill, L. A. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.06.004 · Cited by 333
Diverse physiological functions for dual-specificity MAP kinase phosphatases
Dickinson, R. J., & Keyse, S. M. (2006) · Journal of Cell Science · doi:10.1242/jcs.03266 · Cited by 329
Newton, R. C., & Holden, N. S. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038794 · Cited by 329
Mechanisms and resistance in glucocorticoid control of inflammation
Barnes, P. J. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.018 · Cited by 317
Targeting innate immunity protein kinase signalling in inflammation
Gaestel, M., Kotlyarov, A., & Kracht, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2829 · Cited by 323
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Vandevyver, S., Dejager, L., Tuckermann, J., & Libert, C. (2013) · Endocrinology · doi:10.1210/en.2012-2045 · Cited by 296
Minireview: Latest Perspectives on Antiinflammatory Actions of Glucocorticoids
De Bosscher, K., & Haegeman, G. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0283 · Cited by 284
Anti-inflammatory functions of glucocorticoid-induced genes
Clark, A. R. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.04.013 · Cited by 276
Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases
Hardy, R., Raza, K., & Cooper, M. S. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0371-y · Cited by 273
DUSPs, to MAP kinases and beyond
Huang, C.-Y., & Tan, T.-H. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-24 · Cited by 260
Goyal, R. N., Gupta, V. K., & Chatterjee, S. (2008) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2008.08.024 · Cited by 256
Hartmann, K., Koenen, M., Schauer, S., Wittig-Blaich, S., Ahmad, M., Baschant, U., & Tuckermann, J. P. (2016) · Physiological Reviews · doi:10.1152/physrev.00011.2015 · Cited by 251
Bhattacharyya, S., Brown, D. E., Brewer, J. A., Vogt, S. K., & Muglia, L. J. (2007) · Blood · doi:10.1182/blood-2006-10-048215 · Cited by 249
Molecular Mechanisms of Corticosteroid Resistance
Adcock, I. M., & Barnes, P. J. (2008) · CHEST Journal · doi:10.1378/chest.08-0440 · Cited by 228
p38 Mitogen-Activated Protein Kinase Pathways in Asthma and COPD
Chung, K. F. (2011) · CHEST Journal · doi:10.1378/chest.10-1914 · Cited by 226
Mechanisms Generating Diversity in Glucocorticoid Receptor Signaling
Revollo, J. R., & Cidlowski, J. A. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04986.x · Cited by 220
Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds
Sundahl, N., Bridelance, J., Libert, C., Bosscher, K. D., & Beck, I. M. E. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.001 · Cited by 220
Resolution of inflammation: Mechanisms and opportunity for drug development
Alessandri, A. L., Sousa, L. P., Lucas, C. D., Rossi, A. G., Pinho, V., & Teixeira, M. M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.04.006 · Cited by 219
Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor
Clark, A. R., & Belvisi, M. G. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.12.004 · Cited by 209
Self-citationTargeting protein kinases for the development of anti-inflammatory drugs
Cohen, P. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.01.015 · Cited by 207
Πέττα, Ι., Dejager, L., Ballegeer, M., Lievens, S., Tavernier, J. H., Bosscher, K. D., & Libert, C. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00064-15 · Cited by 212
New dimension of glucocorticoids in cancer treatment
Lin, K., & Wang, L. (2016) · Steroids · doi:10.1016/j.steroids.2016.02.019 · Cited by 204
More Than Suppression: Glucocorticoid Action on Monocytes and Macrophages
Ehrchen, J. M., Roth, J., & Barczyk‐Kahlert, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02028 · Cited by 205
Ayroldi, E., Cannarile, L., Migliorati, G., Nocentini, G., Delfino, D. V., & Riccardi, C. (2012) · The FASEB Journal · doi:10.1096/fj.12-216382 · Cited by 207
Chauhan, S. S., Rashamol, V. P., Bagath, M., Sejian, V., & Dunshea, F. R. (2021) · International Journal of Biometeorology · doi:10.1007/s00484-021-02083-3 · Cited by 192
Control of immunity by glucocorticoids in health and disease
Shimba, A., & Ikuta, K. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00827-8 · Cited by 184
The TLR and IL-1 signalling network at a glance
Cohen, P. (2014) · Journal of Cell Science · doi:10.1242/jcs.149831 · Cited by 186
The Role of Glucocorticoids in Inflammatory Diseases
Reichardt, S. D., Amouret, A., Muzzi, C., Vettorazzi, S., Tuckermann, J. P., Lühder, F., & Reichardt, H. M. (2021) · Cells · doi:10.3390/cells10112921 · Cited by 191
Dual-specificity phosphatase 1: a critical regulator of innate immune responses
Abraham, S., & Clark, A. R. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341018 · Cited by 169
Kleiman, A., & Tuckermann, J. P. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.009 · Cited by 165
Self-citationNew insights into the cell- and tissue-specificity of glucocorticoid actions
Quatrini, L., & Ugolini, S. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00526-2 · Cited by 174
Kaur, M., Chivers, J. E., Giembycz, M. A., & Newton, R. C. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.040121 · Cited by 161
Therapeutic approaches to asthma–chronic obstructive pulmonary disease overlap syndromes
Barnes, P. J. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.05.052 · Cited by 161
Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression
Löwenberg, M., Verhaar, A. P., van den Brink, G. R., & Hommes, D. W. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.02.001 · Cited by 160
Dual-Specificity Phosphatases in Immunity and Infection: An Update
Lang, R., & Raffi, F. A. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112710 · Cited by 156
Kleiman, A., Hübner, S., Parkitna, J. M. R., Neumann, A., Hofer, S., Weigand, M. A., Bauer, M., Schmid, W., Schütz, G., Libert, C., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-192112 · Cited by 152
Regulation of innate immune response by MAP kinase phosphatase-1
Wang, X., & Liu, Y. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.03.013 · Cited by 152
Glucocorticoid receptors: finding the middle ground
Desmet, S. J., & Bosscher, K. D. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88886 · Cited by 152
Glucocorticoid Signaling: An Update from a Genomic Perspective
Sacta, M. A., Chinenov, Y. V., & Rogatsky, I. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105323 · Cited by 155
Dual-specificity MAP kinase phosphatases in health and disease
Seternes, O. M., Kidger, A. M., & Keyse, S. M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.09.002 · Cited by 148
Fighting the Fire: Mechanisms of Inflammatory Gene Regulation by the Glucocorticoid Receptor
Escoter-Torres, L., Caratti, G., Mechtidou, A., Tuckermann, J. P., Uhlenhaut, N. H., & Vettorazzi, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01859 · Cited by 156
TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice
González-Navajas, J. M., Fine, S., Law, J. K., Datta, S. K., Nguyen, K. P., Yu, M., Corr, M., Katakura, K., Eckmann, L., Lee, J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40055 · Cited by 143
Barnes, P. J. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_62 · Cited by 142
Minireview: glucocorticoids in autoimmunity: unexpected targets and mechanisms
Flammer, J. R., & Rogatsky, I. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-0068 · Cited by 140
The multiple facets of glucocorticoid action in rheumatoid arthritis
Baschant, U., Lane, N. E., & Tuckermann, J. P. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.166 · Cited by 140
The Type I Interferon Signaling Pathway Is a Target for Glucocorticoid Inhibition
Flammer, J. R., Dobrovolná, J., Kennedy, M. A., Chinenov, Y. V., Glass, C. K., Ivashkiv, L. B., & Rogatsky, I. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00146-10 · Cited by 135
Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation
Vandevyver, S., Dejager, L., Bogaert, T. V., Kleyman, A., Liu, Y., Tuckermann, J. P., & Libert, C. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60006 · Cited by 133
Chinenov, Y., & Rogatsky, I. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.04.014 · Cited by 133
Role of Dual-Specificity Phosphatase 1 in Glucocorticoid-Driven Anti-inflammatory Responses
Hoppstädter, J., & Ammit, A. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01446 · Cited by 131
Inhibition of NF-κB-dependent Transcription by MKP-1
King, E. M., Holden, N. S., Gong, W., Rider, C. F., & Newton, R. C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028381 · Cited by 129
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
Pathania, A. S., Prathipati, P., Abdul, B. A., Chava, S. P., Katta, S. S., Gupta, S. C., Gangula, P. R., Pandey, M. K., Durden, D. L., Byrareddy, S. N., et al. (2020) · Theranostics · doi:10.7150/thno.51471 · Cited by 131
Giembycz, M. A., Kaur, M., Leigh, R., & Newton, R. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707627 · Cited by 122
Shipp, L. E., Lee, J. V., Yu, C.-Y., Pufall, M. A., Zhang, P., Scott, D. K., & Wang, J.-C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013754 · Cited by 123
Foreign Body Reaction to Subcutaneous Implants
Kastellorizios, M., Tipnis, N. P., & Burgess, D. J. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-18603-0_6 · Cited by 118
Prostaglandins and bone metabolism
Choudhary, S., & Pilbeam, C. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00051-8 · Cited by 116
Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012518 · Cited by 115
Shibata, M., Katsuyama, M., Onodera, T., Ehama, R., Hosoi, J., & Tagami, H. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.237 · Cited by 116
Newton, R. C., Leigh, R., & Giembycz, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.003 · Cited by 117
Effects of Glucocorticoids in the Immune System
Oppong, E. K., & Cato, A. C. B. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2895-8_9 · Cited by 114
Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs
Gaffey, K., Reynolds, S., Plumb, J., Kaur, M., & Singh, D. (2012) · European Respiratory Journal · doi:10.1183/09031936.00170711 · Cited by 111
Singh, D., Smyth, L. J. C., Borrill, Z., Sweeney, L. M., & Tal‐Singer, R. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009347873 · Cited by 108
Du, J., Cheng, B., Zhu, X., & Ling, C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002579 · Cited by 110
Staab-Weijnitz, C. A., & Maser, E. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.013 · Cited by 105
Mitogen-activated protein kinases as therapeutic targets for asthma
Khorasanizadeh, M., Eskian, M., Gelfand, E. W., & Rezaei, N. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.024 · Cited by 107
Anti-inflammatory glucocorticoids: Changing concepts
Newton, R. C. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.05.035 · Cited by 104
Watts, A. M., Cripps, A. W., West, N. P., & Cox, A. J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00294 · Cited by 112
Pre-established Chromatin Interactions Mediate the Genomic Response to Glucocorticoids
D’Ippolito, A. M., McDowell, I. C., Barrera, A., Hong, L. K., Leichter, S. M., Bartelt, L. C., Vockley, C. M., Majoros, W. H., Safi, A., Song, L., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2018.06.007 · Cited by 106
Tristetraprolin Is Required for Full Anti-Inflammatory Response of Murine Macrophages to IL-10
Schaljo, B., Kratochvill, F., Gratz, N., Sadzak, I., Sauer, I., Hammer, M., Vogl, C., Strobl, B., Müller, M. M., Blackshear, P. J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803883 · Cited by 102
Chang, F.-M., Reyna, S. M., Granados, J. C., Wei, S., Innis‐Whitehouse, W., Maffi, S. K., Rodriguez, E., Slaga, T. J., & Short, J. D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.397703 · Cited by 99
Protein tyrosine phosphatases: dual‐specificity phosphatases in health and disease
Pulido, R., & van Huijsduijnen, R. H. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06250.x · Cited by 97
Steroid resistance in asthma: Mechanisms and treatment options
Adcock, I. M., Ford, P. A., Bhavsar, P. K., Ahmad, T., & Chung, K. F. (2008) · Current Allergy and Asthma Reports · doi:10.1007/s11882-008-0028-4 · Cited by 97
Dexamethasone Intravitreal Implant for Treatment of Patients with Persistent Diabetic Macular Edema
Dutra-Medeiros, M., Postorino, M., Navarro, R., García‐Arumí, J., Mateo, C., & Corcóstegui, B. (2013) · Ophthalmologica · doi:10.1159/000356413 · Cited by 97
The p38 MAPK Pathway in Rheumatoid Arthritis: A Sideways Look
Clark, A. R., & Dean, J. L. (2012) · The Open Rheumatology Journal · doi:10.2174/1874312901206010209 · Cited by 97
Role of Dual Specificity Phosphatases in Biological Responses to Glucocorticoids
Clark, A. R., Martins, J. R. S., & Tchen, C. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r700053200 · Cited by 95
Two Phases of Inflammatory Mediator Production Defined by the Study of IRAK2 and IRAK1 Knock-in Mice
Pauls, E., Nanda, S. K., Smith, H., Toth, R. L., Arthur, J. S. C., & Cohen, P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203268 · Cited by 91
Signal integration, crosstalk mechanisms and networks in the function of inflammatory cytokines
Schmitz, M. L., Weber, A., Roxlau, T., Gaestel, M., & Kracht, M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.06.019 · Cited by 99
Newton, R., Shah, S., Altonsy, M. O., & Gerber, A. N. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.777318 · Cited by 91
Clark, A. R., & Dean, J. L. E. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160166 · Cited by 91
Doni, A., Mantovani, G., Porta, C., Tuckermann, J. P., Reichardt, H. M., Kleiman, A., Sironi, M., Rubino, L., Pasqualini, F., Nebuloni, M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805631200 · Cited by 89
Inflammation in the Pathogenesis of Lyme Neuroborreliosis
Ramesh, G., Didier, P. J., England, J. D., Santana-Gould, L., Doyle‐Meyers, L. A., Martin, D. S., Jacobs, M. B., & Philipp, M. T. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.01.024 · Cited by 87
Mechanisms of Disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis
Ayoub, S., Hickey, M. J., & Morand, E. F. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0701 · Cited by 84
The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis
Patel, H., Kornerup, K. N., Sampaio, A. L. F., D’Acquisto, F., Seed, M. P., Girol, A. P., Gray, M., Pitzalis, C., Oliani, S. M., & Perretti, M. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201180 · Cited by 84
BCL-2 protects human and mouse Th17 cells from glucocorticoid-induced apoptosis
Banuelos, J., Shin, S. C., Cao, Y., Bochner, B. S., Morales‐Nebreda, L., Budinger, G. R. S., Zhou, L., Li, S., Xin, J. J., Lingen, M. W., et al. (2016) · Allergy · doi:10.1111/all.12840 · Cited by 82
Shah, S., King, E. M., Chandrasekhar, A., & Newton, R. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.540799 · Cited by 81
Metadata
- Authors
- Abraham, S. M., Lawrence, T., Kleiman, A., Warden, P., Medghalchi, M., Tuckermann, J., Saklatvala, J., & Clark, A. R.
- Affiliations
- Imperial College London (GB)
- Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) (DE)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-07-31
- Volume
- 203
- Issue
- 8
- Pages
- 1883-1889
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118371
- OpenAlex
- W2159379486
- Cited by
- 430
- References
- 29
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 12 · 2023: 22 · 2022: 12 · 2021: 19 · 2020: 12 · 2019: 17 · 2018: 13 · 2017: 21 · 2016: 23 · 2015: 24 · 2014: 33 · 2013: 27 · 2012: 28
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- dexamethasone, glucocorticoids, MKP-1, MAPK phosphatase, macrophages, c-Jun N-terminal kinase, p38 MAPK, pro-inflammatory gene expression, TNF-α, cyclooxygenase-2, interleukin-1, zymosan-induced inflammation, MAPK dephosphorylation
- MeSH terms
- Animals, Anti-Inflammatory Agents, Bone Marrow, Dexamethasone, Dose-Response Relationship, Drug, Enzyme Induction, Gene Expression Regulation, Glucocorticoids, Inflammation, Macrophages, Phosphoprotein Phosphatases, RNA, Messenger, Signal Transduction, Protein Tyrosine Phosphatases, Immediate-Early Proteins, Cell Cycle Proteins, JNK Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Mice, Dual Specificity Phosphatase 1, Protein Phosphatase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review